Letter


DOI :10.26650/IUITFD.1133431   IUP :10.26650/IUITFD.1133431    Full Text (PDF)

THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS

Pathum SookaromdeeViroj Wiwanitkit

.


PDF View

References

  • 1. Hsia W. Emerging new coronavirus infection in Wuhan, China: situation in early 2020. Case Study Case Rep 2020;10:8-9. google scholar
  • 2. Soleimanpour S, Yaghoubi A. COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccines 2021;20(1):23-44. [CrossRef] google scholar
  • 3. Shekhar R, Garg I, Pal S, Kottewar S, Sheikh AB. COVID-19 Vaccine booster: to boost or not to boost. Infect Dis Rep 2021;13(4):924-929. [CrossRef] google scholar
  • 4. Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, et al. Considerations in boosting COVID-19 vaccine immune responses. Lancet 2021;398(10308):1377-80. [CrossRef] google scholar
  • 5. Mahase E. COVID-19: third vaccine dose boosts immune response but may not be needed, say researchers. BMJ 2021;373:n1659. [CrossRef] google scholar
  • 6. Burki TK. Fourth dose of COVID-19 vaccines in Israel. Lancet Respir Med 2022;10(2):e19. [CrossRef] google scholar
  • 7. Abedon AT, Teles MS, Alejo JL, Kim JD, Mitchell J, Chiang TPY, et al. Improved antibody response after a fifth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series. Transplantation 2022;106(5):e262-3. [CrossRef] google scholar
  • 8. Osmanodja B, Ronicke S, Budde K, Jens A, Hammett C, Koch N, et al. Serological response to three, four and five doses of SARS-CoV-2 vaccine in kidney transplant recipients. J Clin Med 2022;11(9):2565. [CrossRef] google scholar
  • 9. Sookaromdee P, Wiwanitkit V. New COVID-19 vaccines, its cost and shelf life: a cost effectiveness analysis. Arch Med Res 2021;52(4):453. [CrossRef] google scholar
  • 10. Yasri S, Wiwanitkit V. Expected response to the additional third dose of COVID-19 vaccine based on different complete standard vaccination background. Int J Physiol Pathophysiol Pharmacol 2022;14(1):1-3. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Sookaromdee, P., & Wiwanitkit, V. (2019). THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. Journal of Istanbul Faculty of Medicine, 0(0), -. https://doi.org/10.26650/IUITFD.1133431


AMA

Sookaromdee P, Wiwanitkit V. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. Journal of Istanbul Faculty of Medicine. 2019;0(0):-. https://doi.org/10.26650/IUITFD.1133431


ABNT

Sookaromdee, P.; Wiwanitkit, V. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. Journal of Istanbul Faculty of Medicine, [Publisher Location], v. 0, n. 0, p. -, 2019.


Chicago: Author-Date Style

Sookaromdee, Pathum, and Viroj Wiwanitkit. 2019. “THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS.” Journal of Istanbul Faculty of Medicine 0, no. 0: -. https://doi.org/10.26650/IUITFD.1133431


Chicago: Humanities Style

Sookaromdee, Pathum, and Viroj Wiwanitkit. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS.” Journal of Istanbul Faculty of Medicine 0, no. 0 (Aug. 2022): -. https://doi.org/10.26650/IUITFD.1133431


Harvard: Australian Style

Sookaromdee, P & Wiwanitkit, V 2019, 'THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS', Journal of Istanbul Faculty of Medicine, vol. 0, no. 0, pp. -, viewed 18 Aug. 2022, https://doi.org/10.26650/IUITFD.1133431


Harvard: Author-Date Style

Sookaromdee, P. and Wiwanitkit, V. (2019) ‘THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS’, Journal of Istanbul Faculty of Medicine, 0(0), pp. -. https://doi.org/10.26650/IUITFD.1133431 (18 Aug. 2022).


MLA

Sookaromdee, Pathum, and Viroj Wiwanitkit. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS.” Journal of Istanbul Faculty of Medicine, vol. 0, no. 0, 2019, pp. -. [Database Container], https://doi.org/10.26650/IUITFD.1133431


Vancouver

Sookaromdee P, Wiwanitkit V. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. Journal of Istanbul Faculty of Medicine [Internet]. 18 Aug. 2022 [cited 18 Aug. 2022];0(0):-. Available from: https://doi.org/10.26650/IUITFD.1133431 doi: 10.26650/IUITFD.1133431


ISNAD

Sookaromdee, Pathum - Wiwanitkit, Viroj. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS”. Journal of Istanbul Faculty of Medicine 0/0 (Aug. 2022): -. https://doi.org/10.26650/IUITFD.1133431



TIMELINE


Submitted20.06.2022
Accepted04.07.2022
Published Online02.08.2022

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.